Skip to main content
Top
Published in: Heart and Vessels 12/2018

01-12-2018 | Original Article

Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms

Authors: Irene Lambrinoudaki, Panagiota Chatzivasileiou, Stefanos Stergiotis, Eleni Armeni, Dimitrios Rizos, George Kaparos, Areti Augoulea, Andreas Alexandrou, Georgios Georgiopoulos, Aggeliki Laina, Kimon Stamatelopoulos

Published in: Heart and Vessels | Issue 12/2018

Login to get access

Abstract

Genetic variations of genes encoding the endothelial nitric oxide synthase (eNOS) and the NADH/NADPH oxidase system are related with atherosclerosis in the general population, but their significance in women is not sufficiently assessed. We investigated the potential association between the G894T polymorphism of the NOS3 gene and the C242T polymorphism of the CYBA gene with subclinical vascular disease. Seventy (70) healthy, normally ovulating, premenopausal women were recruited for this study. Venous blood samples were obtained for biochemical/hormonal assessment as well as for genotyping, using real-time PCR. Sonographically assessed indices of vascular structure and function included carotid and femoral intima-media thickness (IMT), flow-mediated dilation (FMD), carotid-femoral pulse-wave velocity (PWV), and augmentation index. The prevalence of wild type, heterozygote, and homozygote genotype was 44.3% (31/70), 54.3% (38/70), and 1.4% (1/70) for the G894T polymorphism and 38.6% (27/70), 31.4% (22/70), and 30.0% (21/70) for the C242T polymorphism, respectively. After multivariable adjustment, the hC242T polymorphism was a predictor of both internal carotid IMT (b-coefficient − 0.119, p = 0.011) and combined-IMT (b-coefficient − 0.061, p = 0.015). Systolic blood pressure, lipids, and hC242T determined values of FMD (b-coefficient − 1.604, p = 0.034). Concerning the NOS3 G894T polymorphism, carriers of the polymorphic variant had higher values of IMT and PWV compared to the wild-type subgroup (carotid bulb-IMT and PWV, heterozygotes/homozygotes vs wild type 0.7 ± 0.2 vs 0.6 ± 0.1 mm; 7.1 ± 0.8 vs 6.6 ± 0.7 m/s; p = 0.048 and p = 0.029, respectively). These differences, however, were rendered non-significant in the multivariable analysis. In healthy premenopausal women, the CYBA C242T polymorphism is an independent determinant of endothelial function and subclinical atherosclerosis of the carotid arteries. The NOS3 G894T polymorphic variant also correlated with atherosclerosis, an association probably mediated by the traditional risk factors for CVD. The relevance of these findings in the clinical setting remains to be elucidated.
Literature
3.
go back to reference Sallam T, Watson KE (2013) Predictors of cardiovascular risk in women. Womens Health 9(5):491–498 Sallam T, Watson KE (2013) Predictors of cardiovascular risk in women. Womens Health 9(5):491–498
5.
go back to reference Ashley EA, Hershberger RE, Caleshu C, Ellinor PT, Garcia JGN, Herrington DM, Ho CY, Johnson JA, Kittner SJ, MacRae CA, Mudd-Martin G, Rader DJ, Roden DM, Scholes D, Sellke FW, Towbin JA, Van Eyk J, Worrall BB (2012) Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation 126(1):142–157CrossRef Ashley EA, Hershberger RE, Caleshu C, Ellinor PT, Garcia JGN, Herrington DM, Ho CY, Johnson JA, Kittner SJ, MacRae CA, Mudd-Martin G, Rader DJ, Roden DM, Scholes D, Sellke FW, Towbin JA, Van Eyk J, Worrall BB (2012) Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation 126(1):142–157CrossRef
6.
go back to reference Martinelli NC, Santos KG, Biolo A, La Porta VL, Cohen CR, Silvello D, Andrades ME, Clausell N, Rohde LE (2012) Polymorphisms of endothelial nitric oxide synthase gene in systolic heart failure: an haplotype analysis. Nitric Oxide 26(3):141–147CrossRef Martinelli NC, Santos KG, Biolo A, La Porta VL, Cohen CR, Silvello D, Andrades ME, Clausell N, Rohde LE (2012) Polymorphisms of endothelial nitric oxide synthase gene in systolic heart failure: an haplotype analysis. Nitric Oxide 26(3):141–147CrossRef
7.
go back to reference Rai H, Parveen F, Kumar S, Kapoor A, Sinha N (2014) Association of endothelial nitric oxide synthase gene polymorphisms with coronary artery disease: an updated meta-analysis and systematic review. PLoS One 9(11):e113363CrossRef Rai H, Parveen F, Kumar S, Kapoor A, Sinha N (2014) Association of endothelial nitric oxide synthase gene polymorphisms with coronary artery disease: an updated meta-analysis and systematic review. PLoS One 9(11):e113363CrossRef
8.
go back to reference Luo JQ, Wen JG, Zhou HH, Chen XP, Zhang W (2014) Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21,068 subjects. PLoS One 9(1):e87196CrossRef Luo JQ, Wen JG, Zhou HH, Chen XP, Zhang W (2014) Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21,068 subjects. PLoS One 9(1):e87196CrossRef
9.
go back to reference Rafiq A, Aslam K, Malik R, Afroze D (2014) C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension. Mol Med Rep 9(5):1857–1862CrossRef Rafiq A, Aslam K, Malik R, Afroze D (2014) C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension. Mol Med Rep 9(5):1857–1862CrossRef
10.
go back to reference Streeter J, Thiel W, Brieger K, Miller FJ Jr (2013) Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease. Cardiovasc Ther 31(3):125–137CrossRef Streeter J, Thiel W, Brieger K, Miller FJ Jr (2013) Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease. Cardiovasc Ther 31(3):125–137CrossRef
11.
go back to reference Brandes RP (2010) Vascular functions of NADPH oxidases. Hypertension 56(1):17–21CrossRef Brandes RP (2010) Vascular functions of NADPH oxidases. Hypertension 56(1):17–21CrossRef
12.
go back to reference San Jose G, Fortuno A, Beloqui O, Diez J, Zalba G (2008) NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci 114(3):173–182CrossRef San Jose G, Fortuno A, Beloqui O, Diez J, Zalba G (2008) NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci 114(3):173–182CrossRef
13.
go back to reference Li P, Qiu T, Qin C (2015) NADPH oxidase p22phox C242T polymorphism and ischemic cerebrovascular disease: an updated meta-analysis. Med Sci Monit 21:231–238CrossRef Li P, Qiu T, Qin C (2015) NADPH oxidase p22phox C242T polymorphism and ischemic cerebrovascular disease: an updated meta-analysis. Med Sci Monit 21:231–238CrossRef
14.
go back to reference Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak JF, Shea S, Sidney S, O’Leary DH, Chan C, Lloyd-Jones DM (2009) Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 119(3):382–389CrossRef Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak JF, Shea S, Sidney S, O’Leary DH, Chan C, Lloyd-Jones DM (2009) Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 119(3):382–389CrossRef
17.
go back to reference Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191CrossRef Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191CrossRef
18.
go back to reference Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ (2000) A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86(4):391–395CrossRef Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ (2000) A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86(4):391–395CrossRef
19.
go back to reference Nasti S, Spallarossa P, Altieri P, Garibaldi S, Fabbi P, Polito L, Bacino L, Brunelli M, Brunelli C, Barsotti A, Ghigliotti G (2006) C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians. Dis Mark 22(3):167–173CrossRef Nasti S, Spallarossa P, Altieri P, Garibaldi S, Fabbi P, Polito L, Bacino L, Brunelli M, Brunelli C, Barsotti A, Ghigliotti G (2006) C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians. Dis Mark 22(3):167–173CrossRef
20.
go back to reference Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M (1998) Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97(2):135–137CrossRef Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M (1998) Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97(2):135–137CrossRef
21.
go back to reference Castejon AM, Bracero J, Hoffmann IS, Alfieri AB, Cubeddu LX (2006) NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 20(10):772–779CrossRef Castejon AM, Bracero J, Hoffmann IS, Alfieri AB, Cubeddu LX (2006) NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 20(10):772–779CrossRef
22.
go back to reference Farrag W, Eid M (2008) Association of the C242T polymorphism of the p22 phox gene with advanced carotid atherosclerosis in type 2 diabetes. Mol Med Rep 1(5):679–684PubMed Farrag W, Eid M (2008) Association of the C242T polymorphism of the p22 phox gene with advanced carotid atherosclerosis in type 2 diabetes. Mol Med Rep 1(5):679–684PubMed
23.
go back to reference Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka T, Hatazaki M, Hazama Y, Hori M (2003) Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 26(2):458–463CrossRef Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka T, Hatazaki M, Hazama Y, Hori M (2003) Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 26(2):458–463CrossRef
24.
go back to reference Fan M, Raitakari OT, Kahonen M, Juonala M, Hutri-Kahonen N, Marniemi J, Rontu R, Porsti I, Viikari J, Lehtimaki T (2007) CYBA C242T gene polymorphism and flow-mediated vasodilation in a population of young adults: the Cardiovascular Risk in Young Finns Study. J Hypertens 25(7):1381–1387CrossRef Fan M, Raitakari OT, Kahonen M, Juonala M, Hutri-Kahonen N, Marniemi J, Rontu R, Porsti I, Viikari J, Lehtimaki T (2007) CYBA C242T gene polymorphism and flow-mediated vasodilation in a population of young adults: the Cardiovascular Risk in Young Finns Study. J Hypertens 25(7):1381–1387CrossRef
25.
go back to reference Schneider MP, Hilgers KF, Huang Y, Delles C, John S, Oehmer S, Schmieder RE (2003) The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia. Clin Sci 105(1):97–103CrossRef Schneider MP, Hilgers KF, Huang Y, Delles C, John S, Oehmer S, Schmieder RE (2003) The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia. Clin Sci 105(1):97–103CrossRef
26.
go back to reference Fricker R, Hesse C, Weiss J, Tayrouz Y, Hoffmann MM, Unnebrink K, Mansmann U, Haefeli WE (2004) Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation. Br J Clin Pharmacol 58(2):169–177CrossRef Fricker R, Hesse C, Weiss J, Tayrouz Y, Hoffmann MM, Unnebrink K, Mansmann U, Haefeli WE (2004) Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation. Br J Clin Pharmacol 58(2):169–177CrossRef
27.
go back to reference Aa AL, Habib MS, Yaseen RI, Gabr MK, Habeeb RM (2016) Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications. Mol Cell Biochem 421(1–2):103–110 Aa AL, Habib MS, Yaseen RI, Gabr MK, Habeeb RM (2016) Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications. Mol Cell Biochem 421(1–2):103–110
28.
go back to reference Wrzosek M, Sokal M, Sawicka A, Wlodarczyk M, Glowala M, Kosior M, Talalaj M, Biecek P, Nowicka G (2015) Impact of obesity and nitric oxide synthase gene G894T polymorphism on essential hypertension. J Physiol Pharmacol 66(5):681–689PubMed Wrzosek M, Sokal M, Sawicka A, Wlodarczyk M, Glowala M, Kosior M, Talalaj M, Biecek P, Nowicka G (2015) Impact of obesity and nitric oxide synthase gene G894T polymorphism on essential hypertension. J Physiol Pharmacol 66(5):681–689PubMed
29.
go back to reference Niu W, Qi Y (2011) An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS One 6(9):e24266CrossRef Niu W, Qi Y (2011) An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS One 6(9):e24266CrossRef
30.
go back to reference Mitchell GF, Guo CY, Kathiresan S, Vasan RS, Larson MG, Vita JA, Keyes MJ, Vyas M, Newton-Cheh C, Musone SL, Camargo AL, Drake JA, Levy D, O’Donnell CJ, Hirschhorn JN, Benjamin EJ (2007) Vascular stiffness and genetic variation at the endothelial nitric oxide synthase locus: the Framingham Heart Study. Hypertension 49(6):1285–1290CrossRef Mitchell GF, Guo CY, Kathiresan S, Vasan RS, Larson MG, Vita JA, Keyes MJ, Vyas M, Newton-Cheh C, Musone SL, Camargo AL, Drake JA, Levy D, O’Donnell CJ, Hirschhorn JN, Benjamin EJ (2007) Vascular stiffness and genetic variation at the endothelial nitric oxide synthase locus: the Framingham Heart Study. Hypertension 49(6):1285–1290CrossRef
31.
go back to reference Chen W, Srinivasan SR, Li S, Boerwinkle E, Berenson GS (2004) Gender-specific influence of NO synthase gene on blood pressure since childhood: the Bogalusa Heart Study. Hypertension 44(5):668–673CrossRef Chen W, Srinivasan SR, Li S, Boerwinkle E, Berenson GS (2004) Gender-specific influence of NO synthase gene on blood pressure since childhood: the Bogalusa Heart Study. Hypertension 44(5):668–673CrossRef
32.
go back to reference Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD (2006) Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 164(10):921–935CrossRef Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD (2006) Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 164(10):921–935CrossRef
33.
go back to reference Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG (2004) Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298 ⟶ Asp and T-786 ⟶ C polymorphisms. Stroke 35(6):1305–1309CrossRef Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG (2004) Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298 ⟶ Asp and T-786 ⟶ C polymorphisms. Stroke 35(6):1305–1309CrossRef
34.
go back to reference Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Li S, Boerwinkle E, Berenson GS (2004) Nitric oxide synthase gene polymorphism (G894T) influences arterial stiffness in adults: the Bogalusa Heart Study. Am J Hypertens 17(7):553–559CrossRef Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Li S, Boerwinkle E, Berenson GS (2004) Nitric oxide synthase gene polymorphism (G894T) influences arterial stiffness in adults: the Bogalusa Heart Study. Am J Hypertens 17(7):553–559CrossRef
35.
go back to reference Mayer O Jr, Filipovsky J, Pesta M, Cifkova R, Dolejsova M, Simon J (2010) The interaction of endothelial nitric oxide synthase polymorphism and current smoking in terms of increased arterial stiffness. Physiol Res 59(4):529–536PubMed Mayer O Jr, Filipovsky J, Pesta M, Cifkova R, Dolejsova M, Simon J (2010) The interaction of endothelial nitric oxide synthase polymorphism and current smoking in terms of increased arterial stiffness. Physiol Res 59(4):529–536PubMed
36.
go back to reference Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, Benetos A (1998) Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 16(1):31–35CrossRef Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, Benetos A (1998) Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 16(1):31–35CrossRef
Metadata
Title
Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms
Authors
Irene Lambrinoudaki
Panagiota Chatzivasileiou
Stefanos Stergiotis
Eleni Armeni
Dimitrios Rizos
George Kaparos
Areti Augoulea
Andreas Alexandrou
Georgios Georgiopoulos
Aggeliki Laina
Kimon Stamatelopoulos
Publication date
01-12-2018
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 12/2018
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1198-1

Other articles of this Issue 12/2018

Heart and Vessels 12/2018 Go to the issue